BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 35973171)

  • 1. A Combined Baveno VII and Spleen Stiffness Algorithm to Improve the Noninvasive Diagnosis of Clinically Significant Portal Hypertension in Patients With Compensated Advanced Chronic Liver Disease.
    Dajti E; Ravaioli F; Marasco G; Alemanni LV; Colecchia L; Ferrarese A; Cusumano C; Gemini S; Vestito A; Renzulli M; Golfieri R; Festi D; Colecchia A
    Am J Gastroenterol; 2022 Nov; 117(11):1825-1833. PubMed ID: 35973171
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Accuracy of spleen stiffness measurement for the diagnosis of clinically significant portal hypertension in patients with compensated advanced chronic liver disease: a systematic review and individual patient data meta-analysis.
    Dajti E; Ravaioli F; Zykus R; Rautou PE; Elkrief L; Grgurevic I; Stefanescu H; Hirooka M; Fraquelli M; Rosselli M; Chang PEJ; Piscaglia F; Reiberger T; Llop E; Mueller S; Marasco G; Berzigotti A; Colli A; Festi D; Colecchia A;
    Lancet Gastroenterol Hepatol; 2023 Sep; 8(9):816-828. PubMed ID: 37478880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High accuracy of spleen stiffness measurement in diagnosing clinically significant portal hypertension in metabolic-associated fatty liver disease.
    Odriozola A; Puente Á; Cuadrado A; Iruzubieta P; Arias-Loste MT; Redondo C; Rivas C; Fábrega E; Crespo J; Fortea JI
    Liver Int; 2023 Jul; 43(7):1446-1457. PubMed ID: 36912787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validation of Baveno VII criteria for clinically significant portal hypertension by two-dimensional shear wave elastography.
    He R; Liu C; Grgurevic I; Guo Y; Xu H; Liu J; Liu Y; Wang X; Shi H; Madir A; Podrug K; Zhu Y; Hua Y; Wang K; Wen J; Su M; Zhang Q; Li J; Qi X
    Hepatol Int; 2024 Jun; 18(3):1020-1028. PubMed ID: 38740698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation of Baveno VII criteria and other non-invasive diagnostic algorithms for clinically significant portal hypertension in hepatitis delta.
    Jachs M; Sandmann L; Hartl L; Tergast T; Schwarz M; Bauer DJM; Balcar L; Ehrenbauer A; Hofer BS; Cornberg M; Lenzen H; Deterding K; Trauner M; Mandorfer M; Wedemeyer H; Reiberger T; Maasoumy B
    J Hepatol; 2024 Mar; ():. PubMed ID: 38479612
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Sequential Application of Baveno VII Criteria and VITRO Score Improves Diagnosis of Clinically Significant Portal Hypertension.
    Jachs M; Hartl L; Simbrunner B; Bauer D; Paternostro R; Scheiner B; Balcar L; Semmler G; Stättermayer AF; Pinter M; Quehenberger P; Trauner M; Reiberger T; Mandorfer M
    Clin Gastroenterol Hepatol; 2023 Jul; 21(7):1854-1863.e10. PubMed ID: 36244661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. THE ROLE OF ELASTOGRAPHY IN CLINICALLY SIGNIFICANT PORTAL HYPERTENSION.
    Mattos AA; Mattos AZ; Sartori GDP; Both GT; Tovo CV
    Arq Gastroenterol; 2023; 60(4):525-535. PubMed ID: 38018555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validation of non-invasive diagnosis of CSPH in patients with compensated advanced chronic liver disease according to Baveno VII.
    Song BG; Goh MJ; Kang W; Gwak GY; Paik YH; Choi MS; Lee JH; Paik SW; Sinn DH
    Liver Int; 2023 Sep; 43(9):1966-1974. PubMed ID: 37288716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A combined model based on spleen stiffness measurement and Baveno VI criteria to rule out high-risk varices in advanced chronic liver disease.
    Colecchia A; Ravaioli F; Marasco G; Colli A; Dajti E; Di Biase AR; Bacchi Reggiani ML; Berzigotti A; Pinzani M; Festi D
    J Hepatol; 2018 Aug; 69(2):308-317. PubMed ID: 29729368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Baveno VII algorithm outperformed other models in ruling out high-risk varices in individuals with HBV-related cirrhosis.
    Zhang X; Song J; Zhang Y; Wen B; Dai L; Xi R; Wu Q; Li Y; Luo X; Lan X; He Q; Luo W; Lai Q; Ji Y; Zhou L; Qi T; Liu M; Zhou F; Wen W; Li H; Liu Z; Chen Y; Zhu Y; Li J; Huang J; Cheng X; Tu M; Hou J; Wang H; Chen J
    J Hepatol; 2023 Mar; 78(3):574-583. PubMed ID: 36356684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ABC: a novel algorithm to stratify decompensation risk in patients with compensated advanced chronic liver disease (CHESS2108): an international, multicenter cohort study.
    Liu C; Li J; Wong YJ; Xie Q; Hirooka M; Enomoto H; Kim TH; Hanafy AS; He R; Koizumi Y; Hiasa Y; Nishimura T; Iijima H; Jung YK; Yim HJ; Ma J; Zeng QL; Sarin SK; Qi X
    Hepatol Int; 2022 Oct; 16(5):1105-1115. PubMed ID: 35606627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Noninvasive Diagnosis of Portal Hypertension in Patients With Compensated Advanced Chronic Liver Disease.
    Pons M; Augustin S; Scheiner B; Guillaume M; Rosselli M; Rodrigues SG; Stefanescu H; Ma MM; Mandorfer M; Mergeay-Fabre M; Procopet B; Schwabl P; Ferlitsch A; Semmler G; Berzigotti A; Tsochatzis E; Bureau C; Reiberger T; Bosch J; Abraldes JG; Genescà J
    Am J Gastroenterol; 2021 Apr; 116(4):723-732. PubMed ID: 33982942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of clinically significant portal hypertension by two-dimensional shear wave elastography.
    Grgurevic I; Madir A; Trkulja V; Bozin T; Aralica G; Podrug K; Mikolaševic I; Tsochatzis E; O'Beirne J; Pinzani M
    Eur J Clin Invest; 2022 Jun; 52(6):e13750. PubMed ID: 35040495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-Invasive Diagnostic Tests for Portal Hypertension in Patients with HBV- and HCV-Related Cirrhosis: A Comprehensive Review.
    Celsa C; Veneziano M; Di Giorgio FM; Cannova S; Lombardo A; Errigo E; Landro G; Simone F; Sinagra E; Calvaruso V
    Medicina (Kaunas); 2024 Apr; 60(5):. PubMed ID: 38792873
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Shear-wave elastography of the liver and spleen identifies clinically significant portal hypertension: A prospective multicentre study.
    Jansen C; Bogs C; Verlinden W; Thiele M; Möller P; Görtzen J; Lehmann J; Vanwolleghem T; Vonghia L; Praktiknjo M; Chang J; Krag A; Strassburg CP; Francque S; Trebicka J
    Liver Int; 2017 Mar; 37(3):396-405. PubMed ID: 27569696
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Baveno VI and VII criteria are not suitable for screening for large varices or clinically significant portal hypertension in patients with hepatocellular carcinoma.
    Allaire M; Campion B; Demory A; Larrey E; Wagner M; Rudler M; Roux C; Blaise L; Carrie NG; Thabut D
    Aliment Pharmacol Ther; 2023 Aug; 58(3):346-356. PubMed ID: 37300315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of Liver and Spleen Stiffness with Acoustic Radiation Force Impulse Quantification Elastography for Diagnosing Clinically Significant Portal Hypertension.
    Attia D; Schoenemeier B; Rodt T; Negm AA; Lenzen H; Lankisch TO; Manns M; Gebel M; Potthoff A
    Ultraschall Med; 2015 Dec; 36(6):603-10. PubMed ID: 26565516
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elastography, spleen size, and platelet count identify portal hypertension in patients with compensated cirrhosis.
    Berzigotti A; Seijo S; Arena U; Abraldes JG; Vizzutti F; García-Pagán JC; Pinzani M; Bosch J
    Gastroenterology; 2013 Jan; 144(1):102-111.e1. PubMed ID: 23058320
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validation of the New Diagnostic Criteria for Clinically Significant Portal Hypertension by Platelets and Elastography.
    Podrug K; Trkulja V; Zelenika M; Bokun T; Madir A; Kanizaj TF; O'Beirne J; Grgurevic I
    Dig Dis Sci; 2022 Jul; 67(7):3327-3332. PubMed ID: 34739624
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of the Performance of Non-invasive Criteria for the Evaluation of Clinically Significant Portal Hypertension in Patients with Compensated Advanced Chronic Liver Disease.
    Jindal A; Agarwal S; Sharma S; Kumar M; Saraya A; Sarin SK
    Dig Dis Sci; 2023 May; 68(5):2149-2157. PubMed ID: 36562888
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.